| Literature DB >> 23170240 |
Tim Outhred1, Pritha Das, Carol Dobson-Stone, Kristi Griffiths, Kim L Felmingham, Richard A Bryant, Gin Malhi, Andrew H Kemp.
Abstract
An epistatic interaction of 5-HTTLPR and BDNF Val66Met polymorphisms has been implicated in the structure of rostral anterior cingulate cortex (rACC) and amygdala (AMY): key regions associated with emotion processing. However, a functional epistasis of 5-HTTLPR and BDNF Val66Met on overt emotion processing has yet to be determined. Twenty-eight healthy, Caucasian female participants provided saliva samples for genotyping and underwent functional magnetic resonance imaging (fMRI) during which an emotion processing protocol were presented. Confirming the validity of this protocol, we observed blood oxygen level-dependent (BOLD) activity consistent with fMRI meta-analyses on emotion processing. Region-of-interest analysis of the rACC and AMY revealed main effects of 5-HTTLPR and BDNF Val66Met, and an interaction of 5-HTTLPR and BDNF Val66Met. The effect of the BDNF Met66 allele was dependent on 5-HTTLPR alleles, such that participants with S and Met alleles had the greatest rACC and AMY activation during the presentation of emotional images relative to other genetic groupings. Increased activity in these regions was interpreted as increased reactivity to emotional stimuli, suggesting that those with S and Met alleles are more reactive to emotional stimuli relative to other groups. Although limited by a small sample, this study contributes novel and preliminary findings relating to a functional epistasis of the 5-HTTLPR and BDNF Val66Met genes in emotion processing and provides guidance on appropriate methods to determine genetic epistasis in fMRI.Entities:
Keywords: 5-HTTLPR; BDNF Val66Met; emotion processing; epistasis; fMRI; healthy subjects
Year: 2012 PMID: 23170240 PMCID: PMC3500464 DOI: 10.1002/brb3.99
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Participant demographics and IAPS ratings for 5-HTTLPR × BDNF Val66Met allele grouping
| 5-HTTLPR × BDNF Val66Met | |||||
|---|---|---|---|---|---|
| S | L/L | ||||
| Met ( | Val/Val ( | Met ( | Val/Val ( | Test of group differences | |
| Age (years; SD) | 22.00 (4.08) | 25.60 (6.95) | 27.25 (9.62) | 23.09 (4.30) | |
| Menstrual phase (M, N) | 0/4 | 1/4 | 3/5 | 0/11 | χ2 (3) = 6.15; |
| Hormonal birth control (N/Y) | 4/0 | 2/3 | 5/3 | 7/4 | χ2 (3) = 3.52; |
| Handedness (L/R) | 0/4 | 1/4 | 0/8 | 2/9 | χ2 (3) = 2.53; |
| Education (years; SD) | 14.00 (2.65) | 15.20 (2.49) | 13.88 (1.73) | 15.18 (2.86) | |
| PHQ-9 (SD) | 8.00 (7.00) | 5.00 (6.86) | 8.13 (8.68) | 4.70 (5.12) | |
| GAD-7 (SD) | 7.33 (7.07) | 5.40 (5.98) | 5.75 (3.77) | 4.90 (4.33) | |
| Neg valence (SD) | 2.58 (0.28) | 2.37 (0.19) | 2.65 (0.60) | 2.56 (0.53) | |
| Neg arousal (SD) | 6.47 (0.84) | 6.32 (1.40) | 4.99 (2.04) | 5.66 (1.33) | |
| Int valence (SD) | 4.74 (0.21) | 4.45 (0.14) | 4.71 (0.98) | 4.44 (0.40) | |
| Int arousal (SD) | 5.31 (0.35) | 5.22 (1.23) | 4.38 (2.04) | 4.42 (1.33) | |
| Pos valence (SD) | 5.98 (0.91) | 6.85 (0.76) | 6.40 (0.62) | 6.73 (1.13) | |
| Pos arousal (SD) | 5.29 (0.47) | 5.95 (1.27) | 4.90 (1.46) | 5.35 (1.20) | |
SD, standard deviation; M, mid-luteal; N, not mid-luteal; N, no birth control; Y, birth control; Neg, negative; Int, interesting; Pos, positive.
Peak rACC and AMY activation to emotional stimuli for 5-HTTLPR × BDNF Val66Met groupings
| Peak voxel (MNI) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Group contrast | Region | Peak | Effect size | |||||
| Interaction effect | rACC | 327 | <0.001 | −12 | 36 | 24 | ||
| <0.001 | 0 | 36 | 30 | |||||
| <0.001 | −9 | 51 | 0 | |||||
| Left AMY | 35 | 0.035 | −27 | 0 | −18 | |||
| Right AMY | 28 | <0.001 | 27 | −3 | −15 | |||
| 0.003 | 33 | 0 | −27 | |||||
| S and Met > L/L and Met | rACC | 173 | 6.70 | <0.001 | 1.34 | −9 | 36 | 27 |
| 3.35 | 0.001 | 0.67 | −3 | 30 | −3 | |||
| 2.74 | 0.004 | 0.55 | −12 | 42 | 15 | |||
| Left AMY | 45 | 4.94 | 0.027 | 0.99 | −30 | −3 | −18 | |
| Right AMY | 37 | 2.96 | 0.002 | 0.59 | 27 | −9 | −12 | |
| 2.59 | 0.006 | 0.52 | 30 | 3 | −18 | |||
| 2.45 | 0.009 | 0.49 | 21 | −3 | −18 | |||
| S and Val/Val > L/L and Met | Right AMY | 40 | 4.89 | 0.029 | 0.98 | 27 | −6 | −15 |
| 2.16 | 0.018 | 0.43 | 24 | 6 | −18 | |||
| rACC | 254 | 3.81 | <0.001 | 0.76 | −9 | 39 | 24 | |
| 3.16 | 0.001 | 0.63 | −15 | 42 | 12 | |||
| 3.10 | 0.002 | 0.62 | −9 | 51 | 0 | |||
| Left AMY | 25 | 3.03 | 0.002 | 0.61 | −27 | −3 | −15 | |
| L/L and Val/Val > L/L and Met | rACC | 278 | 4.57 | 0.045 | 0.91 | −9 | 36 | 27 |
| 3.03 | 0.002 | 0.61 | 3 | 48 | 27 | |||
| 2.88 | 0.003 | 0.58 | 0 | 30 | −3 | |||
| Right AMY | 33 | 3.77 | 0.001 | 0.75 | 27 | −3 | −15 | |
| 2.63 | <0.001 | 0.53 | 18 | −3 | −15 | |||
| Left AMY | 26 | 3.35 | 0.001 | 0.67 | −27 | −3 | −15 | |
| 2.42 | 0.010 | 0.48 | −18 | −6 | −18 | |||
| S and Met > S and Val/Val | rACC | 9 | 3.02 | 0.002 | 0.60 | −12 | 33 | 27 |
| Left AMY | 14 | 2.44 | 0.009 | 0.49 | −30 | −3 | −18 | |
| S and Met > L/L and Val/Val | rACC | 10 | 3.62 | <0.001 | 0.72 | −12 | 33 | 27 |
| Left AMY | 19 | 2.53 | 0.007 | 0.51 | −30 | −3 | −18 | |
| 1.96 | 0.028 | 0.39 | −21 | 0 | −12 | |||
| S and Val/Val > L/L and Val/Val | Right AMY | 5 | 2.25 | 0.014 | 0.45 | 27 | −6 | −15 |
| S and Val/Val > S and Met | Right AMY | 6 | 1.99 | 0.026 | 0.40 | 27 | −6 | −15 |
| L/L and Met > S and Met | n.s. | |||||||
| L/L and Met > S and Val/Val | n.s. | |||||||
| L/L and Met > L/L and Val/Val | n.s. | |||||||
| L and Val > S and Met | n.s. | |||||||
| L and Val > S and Val/Val | n.s. | |||||||
rACC, bilateral rostral anterior cingulate cortex; AMY, amygdala; k, cluster extent; n.s., no significant voxels; d, Cohen's d.
Partial volume, FDR-corrected P value.
Uncorrected P value.
Figure 1rACC activation to emotional stimuli relative to nonemotional stimuli. (A) Main effect of 5-HTTLPR. (B) Main effect of BDNF Val66Met. (C) Interaction effect of 5-HTTLPR × BDNF Val66Met, demonstrating epistasis. Red dots, S and Met group; Yellow dots, S and Val group; Green dots, L/L and Met group; Blue dots, L/L and Val/Val group.